Triulzi, T., Forte, L., Regondi, V., Di Modica, M., Ghirelli, C., Carcangiu, M. L., . . . Tagliabue, E. (2018). HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy. Oncoimmunology.
Citación estilo ChicagoTriulzi, Tiziana, Luca Forte, Viola Regondi, Martina Di Modica, Cristina Ghirelli, Maria Luisa Carcangiu, Lucia Sfondrini, Andrea Balsari, y Elda Tagliabue. "HER2 Signaling Regulates the Tumor Immune Microenvironment and Trastuzumab Efficacy." Oncoimmunology 2018.
Cita MLATriulzi, Tiziana, et al. "HER2 Signaling Regulates the Tumor Immune Microenvironment and Trastuzumab Efficacy." Oncoimmunology 2018.
Precaución: Estas citas no son 100% exactas.